Company: LIMN
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001410578-25-001746
Chunk: 310

Company: Liminatus Pharma, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 310
---
 Sponsor                | ​ |            — | ​ | ​      |   — | ​ |            — | ​ | ​      |    — | ​ | ​            | -160,677 | ​ | ​          |  160,677 | ​ | ​           |           — | ​ | ​             |           — |
| Remeasurement of Class A common stock to redemption amount            |   |            — | ​ |        |   — | ​ |            — | ​ | ​      |    — | ​ | ​            |        — | ​ |            | -248,882 | ​ |             |           — | ​ |               |    -248,882 |
| Excise tax payable attributable to redemption of Class A common stock | ​ |            — | ​ | ​      |   — | ​ |            — | ​ | ​      |    — | ​ | ​            |        — | ​ | ​          |        — | ​ | ​           |     -25,421 | ​ | ​             |     -25,421 |
| Recovery of excess redemptions - tax claim                            | ​ |            — | ​ | ​      |   — | ​ |            — | ​ | ​      |    — | ​ | ​            |        — | ​ | ​          |        — | ​ | ​           |     294,669 | ​ | ​             |     294,669 |
| Net loss                                                              | ​ |            — | ​ | ​      |   — | ​ |            — | ​ | ​      |    — | ​ | ​            |        — | ​ | ​          |        — | ​ | ​           |  -2,904,299 | ​ | ​             |  -2,904,299 |
| Balance as of December 31, 2024                                       |   |    6,900,000 | ​ | $      | 690 | ​ |            — | ​ | $      |    — | ​ | $            | -160,677 | ​ | $          |   51,795 | ​ | $           | -17,518,175 | ​ | $             | -17,626,367 |

The accompanying notes are an integral part of these financial statements.

F-80

IRIS ACQUISITION CORP STATEMENTS OF CASH FLOWS

| ​                                                                           
 ​                                                                           
 ​                                                                           
 Cash Flows from Operating Activities:                                       | ​ 
 ​ 
 ​